Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,865.90
-14.30 (-0.76%)
At close: Aug 21, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 353.21 billion as of August 21, 2026. Its market cap has increased by 23.88% in one year.
Market Cap
353.21B
Enterprise Value
367.21B
Revenue
96.83B
Ranking
n/a
PE Ratio
34.92
Stock Price
1,865.90
ChartMarket Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 353.21B, an increase of 37.46%. That is a compound annual growth rate of 16.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 353.21B | 36.55% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.02T |
| Dr. Reddy's Laboratories | 975.42B |
| Abbott India | 560.98B |
| GlaxoSmithKline Pharmaceuticals | 488.43B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 298.64B |
| Granules India | 207.68B |
| Caplin Point Laboratories | 195.43B |